Insiders selling stocks may have a plethora of reasons, but when they buy, the message is crystal clear – they anticipate profits. Let’s delve into two striking recent insider purchases.
Firstly, on Monday, Fortress Biotech’s PRESIDENT, Lindsay A. Rosenwald, made a bold move by acquiring 763,359 shares of FBIO at $1.84 each, totaling $1.40 million. Interestingly, FBIO is currently trading at $1.46, a price 20.7% lower than Rosenwald’s purchase. This purchase adds to the series of acquisitions by Rosenwald, who previously bought FBIO thrice over the past year, investing a total of $2.82 million at an average share price of $1.72.
James H. Dahl’s Strategic Investment in AMREP
Turning to Tuesday, James H. Dahl demonstrated confidence in AMREP by purchasing 3,000 shares at $30.75 each, amounting to $92,250. Dahl’s transaction history with AXR is impressive, with this recent buy marking his 28th purchase in the past year. His cumulative investment in AXR stands at $3.34 million, with an average share price of $20.97. Currently, AMREP is trading up about 1% on Thursday.
VIDEO: Thursday 9/26 Insider Buying Report: FBIO, AXR
The insights shared here are based on the author’s perspective and do not necessarily align with those of Nasdaq, Inc.
